RZLT
RZLT
NASDAQ · Biotechnology

Rezolute Inc

$3.79
+0.15 (+4.12%)
As of Nov 7, 2:15 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target +357.8% upside
Low Target $11.58
Average Target $17.35
High Target $20.59
Current Price $3.79
Current
$3.79
Target
$17.35
$11.58 $17.35 avg $20.59
Scenario Analysis
Bear Case
$11.58
205.5%
Low target
Base Case
$17.35
+357.8%
Avg target
Bull Case
$20.59
+443.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$11.46
-66.9% from high
52-Week Low
$1.07
+254.2% from low
Target vs 52W High
$17.35
+51.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%